NEW YORK, Aug. 02, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Mercury Systems, Inc. MRCY
Lead Plaintiff Deadline: September 10, 2018
Class Period: October 24, 2017 and April 24, 2018
Get additional information about MRCY: http://www.wongesq.com/pslra-c/mercury-systems?wire=3
PolarityTE, Inc. COOL
Lead Plaintiff Deadline: August 27, 2018
Class Period: March 31, 2017 and June 22, 2018
Get additional information about COOL: http://www.wongesq.com/pslra-c/polarityte-inc?wire=3
Unum Group UNM
Lead Plaintiff Deadline: August 13, 2018
Class Period: October 27, 2016 and May 1, 2018
Get additional information about UNM: http://www.wongesq.com/pslra-c/unum-group?wire=3
Ormat Technologies, Inc. ORA
Lead Plaintiff Deadline: August 8, 2018
Class Period: August 8, 2017 and May 15, 2018
Get additional information about ORA: http://www.wongesq.com/pslra-c/ormat-technologies-inc-2?wire=3
Deutsche Bank Aktiengesellschaft DB
Lead Plaintiff Deadline: August 6, 2018
Class Period: March 20, 2017 and May 30, 2018
Get additional information about DB: http://www.wongesq.com/pslra-c/deutsche-bank-aktiengesellschaft-2?wire=3
Farmland Partners Inc. FPI
Lead Plaintiff Deadline: September 10, 2018
Class Period: May 9, 2017 and July 10, 2018
Get additional information about FPI: http://www.wongesq.com/pslra-c/farmland-partners-inc?wire=3
Sibanye Gold Limited SBGL
Lead Plaintiff Deadline: August 27, 2018
Class Period: April 7, 2017 and June 26, 2018
Get additional information about SBGL: http://www.wongesq.com/pslra-c/sibanye-gold-limited?wire=3
PG&E Corporation PCG
Lead Plaintiff Deadline: August 13, 2018
Class Period: April 29, 2015 and June 8, 2018
Get additional information about PCG: http://www.wongesq.com/pslra-c/pge-corporation?wire=3
Flex Pharma, Inc. FLKS
Lead Plaintiff Deadline: August 20, 2018
Class Period: November 6, 2017 and June 12, 2018
Get additional information about FLKS: http://www.wongesq.com/pslra-c/flex-pharma-inc?wire=3
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.